Skip to content
Search

Latest Stories

RPS, CPPE collaborate on pathway to recognise advance pharmacist practice in England

The Royal Pharmaceutical Society (RPS) in collaboration with Health Education England’s Centre for Advancing Practice and the Centre for Pharmacy Post Graduate Education (CPPE) will provide a pharmacy-specific professional development pathway for advanced pharmacist practice.

Successful completion of the pathway, assured through the RPS Core Advanced Pharmacist Curriculum assessment, will result in pharmacists being recognized by RPS as an advanced pharmacist, along with the awarding of HEE’s Centre for Advancing Practice’s ‘Advanced’ digital badge, demonstrating the quality assurance of their advanced practice preparation to patients, families, carers, and other healthcare professionals.


The first participants in a fully funded, supported e-portfolio pathway to recognize advanced pharmacist practice in England will get underway in March 2023

This new programme is an important step in creating a clear postgraduate career structure for pharmacists in England.

The innovative approach provides funding from HEE’s Centre for Advancing Practice in 2023-24 for 300 pharmacists in England who are near to, or already practicing at, an advanced level, to enable them to receive supervision and support in building their RPS Core Advanced e-Portfolio from CPPE’s pharmacy education supervisors.

They will work to evidence the outcomes set out in the RPS Core Advanced Pharmacist Curriculum which is focused on delivering holistic care autonomously to people with complex needs.

They will also work to demonstrate the leadership and management, education, and research capabilities of advanced practitioners who are expected to be able to lead service change and improve outcomes for groups of patients.

Eligible pharmacists are those working in advanced practice roles who successfully apply through HEE’s Centre for Advancing Practice for its ePortfolio (supported) Route, including pharmacists who have completed the Primary care pharmacy education pathway with CPPE.

Places for pharmacists in cohorts 1-3 of the ePortfolio (supported) Route have been allocated, and the Centre is planning to make further places available for pharmacists in subsequent cohorts later this year.

Joseph Oakley, Associate Director for Education and Development, at RPS said: “We are proud to have led on this exciting collaboration which marks a milestone in recognising and assuring advanced pharmacist practice in England and we are delighted to be working with our partners on this.

"This pathway strikes the perfect balance between allowing pharmacists to develop specific advanced pharmacist capabilities whilst ensuring alignment with other healthcare professions. It also provides pharmacists with the opportunity to evidence their advanced practice through work-based experiential learning and assessment with the support of a high-quality educational supervisor.”

More For You

Homecare medicines services face many challenges beyond pharmacy's control

Homecare medicines services face many challenges beyond pharmacy's control

gettyimages

GPhC calls for industry-wide collaboration to strengthen homecare medicines services

The General Pharmaceutical Council (GPhC) has called for industry-wide collaboration to improve homecare medicines services to ensure patients always receive their medicines when needed.

The call follows a recent review by the regulator, which identified several challenges facing homecare services, many of which were beyond the immediate control of the pharmacies providing them.

Keep ReadingShow less
Lack of funding deters NI pharmacy contractors from expanding portfolio

W G Hamilton Pharmacy is the third pharmacy in Northern Ireland to be recently sold to first-time buyers.

Pharmacy ownership trends shift in Northern Ireland due to funding gap

An increasing number of pharmacies in Northern Ireland are being acquired by first-time buyers, as existing contractors and groups pull back from expanding their portfolios amid ongoing funding pressures, according to specialist business property adviser Christie & Co.

Among the most recent sales is W G Hamilton Pharmacy, a busy community pharmacy in Ballysillan, North Belfast.

Keep ReadingShow less
RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less